Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer
This study has been completed.
Sponsor:
Hoosier Oncology Group
Collaborators:
Sanofi
Hoffmann-La Roche
Walther Cancer Institute
Information provided by:
Hoosier Oncology Group
ClinicalTrials.gov Identifier:
NCT00216021
First received: September 9, 2005
Last updated: May 7, 2008
Last verified: December 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | June 2007 |
| Estimated Primary Completion Date: | No date given |